A citation-based method for searching scientific literature

Niklas Thon, Sabina Eigenbrod, Eva M Grasbon-Frodl, Michael Ruiter, Jan H Mehrkens, Simone Kreth, Jörg C Tonn, Hans A Kretzschmar, Friedrich W Kreth. J Neuropathol Exp Neurol 2009
Times Cited: 60







List of co-cited articles
415 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The 2007 WHO classification of tumours of the central nervous system.
David N Louis, Hiroko Ohgaki, Otmar D Wiestler, Webster K Cavenee, Peter C Burger, Anne Jouvet, Bernd W Scheithauer, Paul Kleihues. Acta Neuropathol 2007
46

Intratumoral homogeneity of MGMT promoter hypermethylation as demonstrated in serial stereotactic specimens from anaplastic astrocytomas and glioblastomas.
Eva M Grasbon-Frodl, Friedrich Wilhelm Kreth, Michael Ruiter, Oliver Schnell, Karl Bise, Jörg Felsberg, Guido Reifenberger, Jörg-Christian Tonn, Hans A Kretzschmar. Int J Cancer 2007
126
35

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
David N Louis, Arie Perry, Guido Reifenberger, Andreas von Deimling, Dominique Figarella-Branger, Webster K Cavenee, Hiroko Ohgaki, Otmar D Wiestler, Paul Kleihues, David W Ellison. Acta Neuropathol 2016
35

MGMT gene silencing and benefit from temozolomide in glioblastoma.
Monika E Hegi, Annie-Claire Diserens, Thierry Gorlia, Marie-France Hamou, Nicolas de Tribolet, Michael Weller, Johan M Kros, Johannes A Hainfellner, Warren Mason, Luigi Mariani,[...]. N Engl J Med 2005
33

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.
Roger Stupp, Warren P Mason, Martin J van den Bent, Michael Weller, Barbara Fisher, Martin J B Taphoorn, Karl Belanger, Alba A Brandes, Christine Marosi, Ulrich Bogdahn,[...]. N Engl J Med 2005
28

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.
Christian Hartmann, Jochen Meyer, Jörg Balss, David Capper, Wolf Mueller, Arne Christians, Jörg Felsberg, Marietta Wolter, Christian Mawrin, Wolfgang Wick,[...]. Acta Neuropathol 2009
801
28

Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors.
David Capper, Susanne Weissert, Jörg Balss, Antje Habel, Jochen Meyer, Diana Jäger, Ulrike Ackermann, Claudia Tessmer, Andrey Korshunov, Hanswalter Zentgraf,[...]. Brain Pathol 2010
379
26

Hot spots in dynamic (18)FET-PET delineate malignant tumor parts within suspected WHO grade II gliomas.
M Kunz, N Thon, S Eigenbrod, C Hartmann, R Egensperger, J Herms, J Geisler, C la Fougere, J Lutz, J Linn,[...]. Neuro Oncol 2011
161
21

IDH1 and IDH2 mutations in gliomas.
Hai Yan, D Williams Parsons, Genglin Jin, Roger McLendon, B Ahmed Rasheed, Weishi Yuan, Ivan Kos, Ines Batinic-Haberle, Siân Jones, Gregory J Riggins,[...]. N Engl J Med 2009
20

IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival: a grading problem for WHO.
David E Reuss, Yasin Mamatjan, Daniel Schrimpf, David Capper, Volker Hovestadt, Annekathrin Kratz, Felix Sahm, Christian Koelsche, Andrey Korshunov, Adriana Olar,[...]. Acta Neuropathol 2015
182
20

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.
Roger Stupp, Monika E Hegi, Warren P Mason, Martin J van den Bent, Martin J B Taphoorn, Robert C Janzer, Samuel K Ludwin, Anouk Allgeier, Barbara Fisher, Karl Belanger,[...]. Lancet Oncol 2009
18

NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide.
Wolfgang Wick, Christian Hartmann, Corinna Engel, Mandy Stoffels, Jörg Felsberg, Florian Stockhammer, Michael C Sabel, Susanne Koeppen, Ralf Ketter, Richard Meyermann,[...]. J Clin Oncol 2009
564
18

Predominant influence of MGMT methylation in non-resectable glioblastoma after radiotherapy plus temozolomide.
Niklas Thon, Sabina Eigenbrod, Eva M Grasbon-Frodl, Juergen Lutz, Simone Kreth, Gabriele Popperl, Claus Belka, Hans A Kretzschmar, Joerg-Christian Tonn, Friedrich W Kreth. J Neurol Neurosurg Psychiatry 2011
39
28

IDH1 mutations in grade II astrocytomas are associated with unfavorable progression-free survival and prolonged postrecurrence survival.
Niklas Thon, Sabina Eigenbrod, Simone Kreth, Juergen Lutz, Joerg-Christian Tonn, Hans Kretzschmar, Aurelia Peraud, Friedrich-Wilhelm Kreth. Cancer 2012
69
18

ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma.
David E Reuss, Felix Sahm, Daniel Schrimpf, Benedikt Wiestler, David Capper, Christian Koelsche, Leonille Schweizer, Andrey Korshunov, David T W Jones, Volker Hovestadt,[...]. Acta Neuropathol 2015
288
18

Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas.
Marc Sanson, Yannick Marie, Sophie Paris, Ahmed Idbaih, Julien Laffaire, François Ducray, Soufiane El Hallani, Blandine Boisselier, Karima Mokhtari, Khe Hoang-Xuan,[...]. J Clin Oncol 2009
718
16

Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402.
Gregory Cairncross, Brian Berkey, Edward Shaw, Robert Jenkins, Bernd Scheithauer, David Brachman, Jan Buckner, Karen Fink, Luis Souhami, Normand Laperierre,[...]. J Clin Oncol 2006
523
16

Mutational landscape and clonal architecture in grade II and III gliomas.
Hiromichi Suzuki, Kosuke Aoki, Kenichi Chiba, Yusuke Sato, Yusuke Shiozawa, Yuichi Shiraishi, Teppei Shimamura, Atsushi Niida, Kazuya Motomura, Fumiharu Ohka,[...]. Nat Genet 2015
502
16

An integrated genomic analysis of human glioblastoma multiforme.
D Williams Parsons, Siân Jones, Xiaosong Zhang, Jimmy Cheng-Ho Lin, Rebecca J Leary, Philipp Angenendt, Parminder Mankoo, Hannah Carter, I-Mei Siu, Gary L Gallia,[...]. Science 2008
15

How often are nonenhancing supratentorial gliomas malignant? A population study.
J N Scott, P M A Brasher, R J Sevick, N B Rewcastle, P A Forsyth. Neurology 2002
238
15

IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas.
Takuya Watanabe, Sumihito Nobusawa, Paul Kleihues, Hiroko Ohgaki. Am J Pathol 2009
689
13

A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma.
Robert B Jenkins, Hilary Blair, Karla V Ballman, Caterina Giannini, Robert M Arusell, Mark Law, Heather Flynn, Sandra Passe, Sara Felten, Paul D Brown,[...]. Cancer Res 2006
494
13

Molecular imaging of gliomas with PET: opportunities and limitations.
Christian la Fougère, Bogdana Suchorska, Peter Bartenstein, Friedrich-Wilhelm Kreth, Jörg-Christian Tonn. Neuro Oncol 2011
178
13

Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951.
Martin J van den Bent, Alba A Brandes, Martin J B Taphoorn, Johan M Kros, Mathilde C M Kouwenhoven, Jean-Yves Delattre, Hans J J A Bernsen, Marc Frenay, Cees C Tijssen, Wolfgang Grisold,[...]. J Clin Oncol 2013
708
13

ATRX immunostaining predicts IDH and H3F3A status in gliomas.
Azadeh Ebrahimi, Marco Skardelly, Irina Bonzheim, Ines Ott, Helmut Mühleisen, Franziska Eckert, Ghazaleh Tabatabai, Jens Schittenhelm. Acta Neuropathol Commun 2016
71
13

Analysis of the IDH1 codon 132 mutation in brain tumors.
Jörg Balss, Jochen Meyer, Wolf Mueller, Andrey Korshunov, Christian Hartmann, Andreas von Deimling. Acta Neuropathol 2008
759
11

FET PET for the evaluation of untreated gliomas: correlation of FET uptake and uptake kinetics with tumour grading.
Gabriele Pöpperl, Friedrich W Kreth, Jan H Mehrkens, Jochen Herms, Klaus Seelos, Walter Koch, Franz J Gildehaus, Hans A Kretzschmar, Jörg C Tonn, Klaus Tatsch. Eur J Nucl Med Mol Imaging 2007
199
11

FET-PET for malignant glioma treatment planning.
Maximilian Niyazi, Julia Geisler, Axel Siefert, Silke Birgit Schwarz, Ute Ganswindt, Sylvia Garny, Oliver Schnell, Bogdana Suchorska, Friedrich-Wilhelm Kreth, Jörg-Christian Tonn,[...]. Radiother Oncol 2011
99
11

Magnetic resonance imaging and histopathology of cerebral gliomas.
M Watanabe, R Tanaka, N Takeda. Neuroradiology 1992
238
11

MRI-suspected low-grade glioma: is there a need to perform dynamic FET PET?
Nathalie L Jansen, Vera Graute, Lena Armbruster, Bogdana Suchorska, Juergen Lutz, Sabina Eigenbrod, Paul Cumming, Peter Bartenstein, Jörg-Christian Tonn, Friedrich Wilhelm Kreth,[...]. Eur J Nucl Med Mol Imaging 2012
115
11

Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402.
Gregory Cairncross, Meihua Wang, Edward Shaw, Robert Jenkins, David Brachman, Jan Buckner, Karen Fink, Luis Souhami, Normand Laperriere, Walter Curran,[...]. J Clin Oncol 2013
664
11

Mutant IDH1 and thrombosis in gliomas.
Dusten Unruh, Steven R Schwarze, Laith Khoury, Cheddhi Thomas, Meijing Wu, Li Chen, Rui Chen, Yinxing Liu, Margaret A Schwartz, Christina Amidei,[...]. Acta Neuropathol 2016
88
11

Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entities.
David E Reuss, Annekathrin Kratz, Felix Sahm, David Capper, Daniel Schrimpf, Christian Koelsche, Volker Hovestadt, Melanie Bewerunge-Hudler, David T W Jones, Jens Schittenhelm,[...]. Acta Neuropathol 2015
178
11

Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERT.
Melike Pekmezci, Terri Rice, Annette M Molinaro, Kyle M Walsh, Paul A Decker, Helen Hansen, Hugues Sicotte, Thomas M Kollmeyer, Lucie S McCoy, Gobinda Sarkar,[...]. Acta Neuropathol 2017
176
11

Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas.
Nathalie L Albert, Michael Weller, Bogdana Suchorska, Norbert Galldiks, Riccardo Soffietti, Michelle M Kim, Christian la Fougère, Whitney Pope, Ian Law, Javier Arbizu,[...]. Neuro Oncol 2016
353
11

Identification of der(1;19)(q10;p10) in five oligodendrogliomas suggests mechanism of concurrent 1p and 19q loss.
Constance A Griffin, Peter Burger, Laura Morsberger, Raluca Yonescu, Sharon Swierczynski, Jon D Weingart, Kathleen M Murphy. J Neuropathol Exp Neurol 2006
201
10

Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas.
Yoshikazu Okamoto, Pier-Luigi Di Patre, Christoph Burkhard, Sonja Horstmann, Benjamin Jourde, Michael Fahey, Danielle Schüler, Nicole M Probst-Hensch, M Gazi Yasargil, Yasuhiro Yonekawa,[...]. Acta Neuropathol 2004
228
10

Frequent promoter hypermethylation and low expression of the MGMT gene in oligodendroglial tumors.
Maria Möllemann, Marietta Wolter, Jörg Felsberg, V Peter Collins, Guido Reifenberger. Int J Cancer 2005
220
10

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents.
M Esteller, J Garcia-Foncillas, E Andion, S N Goodman, O F Hidalgo, V Vanaclocha, S B Baylin, J G Herman. N Engl J Med 2000
10

IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas.
Koichi Ichimura, Danita M Pearson, Sylvia Kocialkowski, L Magnus Bäcklund, Raymond Chan, David T W Jones, V Peter Collins. Neuro Oncol 2009
430
10




Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
Christian Hartmann, Bettina Hentschel, Wolfgang Wick, David Capper, Jörg Felsberg, Matthias Simon, Manfred Westphal, Gabriele Schackert, Richard Meyermann, Torsten Pietsch,[...]. Acta Neuropathol 2010
529
10

The place of interstitial brachytherapy and radiosurgery for low-grade gliomas.
F W Kreth, N Thon, A Siefert, J C Tonn. Adv Tech Stand Neurosurg 2010
19
31

A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival.
M Lacroix, D Abi-Said, D R Fourney, Z L Gokaslan, W Shi, F DeMonte, F F Lang, I E McCutcheon, S J Hassenbusch, E Holland,[...]. J Neurosurg 2001
10

Dynamic 18F-FET PET in newly diagnosed astrocytic low-grade glioma identifies high-risk patients.
Nathalie L Jansen, Bogdana Suchorska, Vera Wenter, Sabina Eigenbrod, Christine Schmid-Tannwald, Andreas Zwergal, Maximilian Niyazi, Mark Drexler, Peter Bartenstein, Oliver Schnell,[...]. J Nucl Med 2014
96
10

Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.
Daniel J Brat, Roel G W Verhaak, Kenneth D Aldape, W K Alfred Yung, Sofie R Salama, Lee A D Cooper, Esther Rheinbay, C Ryan Miller, Mark Vitucci, Olena Morozova,[...]. N Engl J Med 2015
10

Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors.
Jeanette E Eckel-Passow, Daniel H Lachance, Annette M Molinaro, Kyle M Walsh, Paul A Decker, Hugues Sicotte, Melike Pekmezci, Terri Rice, Matt L Kosel, Ivan V Smirnov,[...]. N Engl J Med 2015
10

Prognostic significance of dynamic 18F-FET PET in newly diagnosed astrocytic high-grade glioma.
Nathalie L Jansen, Bogdana Suchorska, Vera Wenter, Christine Schmid-Tannwald, Andrei Todica, Sabina Eigenbrod, Maximilian Niyazi, Jörg-Christian Tonn, Peter Bartenstein, Friedrich-Wilhelm Kreth,[...]. J Nucl Med 2015
98
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.